Abstract:
Objective To explore the predictive value of serum α1-acid glycoprotein (AGP), epidermal modulin (EREG) combined with electrocardiogram for major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
Methods A total of 187 patients with acute ST-segment elevation myocardial infarction (STEMI) were selected as the research subjects. According to whether MACE occurred within 6 months after PCI, the STEMI patients were divided into the non-MACE group (n = 135) and MACE group (n = 52). The levels of serum AGP and EREG were compared between two groups. The value of serum AGP, EREG, electrocardiogram and combination of the three in predicting MACE in STEMI patients after PCI were analyzed.
Results The levels of serum AGP and EREG in STEMI patients of the MACE group were both higher than those in the group without MACE (P < 0.01). The area under the curve (AUC) of serum AGP and EREG for predicting MACE in STEMI patients after PCI was 0.863 and 0.867, respectively. The sensitivities were 88.46% and 86.54%, respectively. The specificities were 75.56% and 77.04%, respectively. The accuracies were 79.14% and 79.68%, respectively. The sensitivities of electrocardiogram T wave inversion and early ST segment regression < 50% for predicting MACE in STEMI patients after PCI were 69.23% and 90.38% respectively, the specificities were 66.67% and 74.07% respectively, and the accuracies were 67.38% and 78.61% respectively. The combined sensitivity of serum AGP, EREG and early ST-segment regression of electrocardiogram < 50% in predicting MACE in STEMI patients after PCI was 86.54%, the specificity was 97.78%, and the accuracy was 94.65%. Both the specificity and accuracy were higher than those of individual indicators (P < 0.01).
Conclusions Serum AGP, EREG combined with electrocardiogram have a relatively high predictive value for the occurrence of MACE in STEMI patients after PCI, and may be a reference protocol for clinical determination of whether MACE occurs in STEMI patients after PCI.